Please login or register first to view this content.
Oncology
AI-Based Smartphone App Can Help Cut Cancer Pain Severity
ASCO: Alcohol consumption increases cancer risk
Adjuvant Pembrolizumab Beneficial in Stage III Melanoma
Advanced Ovarian Cancer Survival Rates Longer After Primary Cytoreductive Surgery Compared With Neoadjuvant Chemotherapy
Angiotensin-Converting Enzyme Inhibitors May Increase Lung Cancer Risk
Aspirin, Non-Aspirin NSAID Use May Improve Survival Outcomes in Ovarian Cancer
Assessing the impact of antidepressants on ovarian cancer risk
Authors Explore Overdiagnosis in Cancer Screening
Avastin Plus ChemoTx Approved for Advanced Ovarian Cancer After Resection
Barriers to Prostate Cancer Research in Black Men Identified
Better Efforts Needed for Cancer Patients With Pessimistic Illness Perceptions
Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes
CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
Cancer Patients Treated With Step III Opioids Often Have Sleep Disturbances
Cancer Screening Nonadherence May Be Associated With Increase in Overall Mortality
Cancer history affects mortality risk independent of CV risk
Cancer risk in women who work night shifts long-term
Checkpoint Inhibitor Pneumonitis in NSCLC
Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
Chemotherapy Plays a Role in Skeletal Muscle Atrophy in Patients With Breast Cancer
Chemotherapy With Bevacizumab May Improve Some Ovarian Cancer Outcomes, Worsen Others
Classical Massage Mitigates CIPN Due to Adjuvant Chemotherapy for Breast Cancer
Clinical tool may help in prostate cancer screenings
Colorectal cancer risk in veterans significantly reduced with colonoscopy screening
Colorectal cancer screening doubled with use of a digital health program
Cooling therapy for hand-foot syndrome prevention, management
Coordinated Care Needed for Cancer Survivors, Caregivers
Copy Number Abnormalities May Inform Survival, Drug Resistance
FDA Approves Multi-Cancer Treatment Drug
FDA Grants First Approval for CA Drug Under New Pilot Programs
FDA Targets Clinics Offering Unapproved Stem Cell Therapies
Fewer Complications Found With Hybrid Surgery for Esophageal Cancer
Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men
Gap identified in colorectal cancer screening among low-income populations
Genomic Screening Can ID Undetected BRCA1/2 Cancer Risk
Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
Handheld Device Can ID Cardiac Dysfunction in Cancer Survivors
High vitamin D concentration associated with lower cancer risk
Higher Levels of Anti-CA15.3 and Anti-CA125 Linked to Increased Risk for Mucinous Epithelial Ovarian Cancer
Higher Risk of In Situ Breast CA, Ovarian Tumors With Fertility Treatment
Higher Sensitivity With 1-View Digital Breast Tomosynthesis for Breast Cancer Detection
Higher Vitamin D Levels Tied to Lower Risk of Colorectal Cancer
Highly Selective, First-in-Class CDK4 Inhibitor Promising in Ovarian Cancer
Immunotherapy Side Effects May Be More Common Than Thought
Increase in Global Cancer Incidence, Drop in Death Rates
Induction Chemotherapy Is Well Tolerated in Elderly Patients With Acute Myeloid Leukemia
Investigational Therapy Gets Fast Track Status for Recurrent Ovarian Cancer
Link for Asbestos-Free Talcum Powder, Cancer Not Clear
Lumpectomy + Radiation May Cut Breast Cancer Mortality in DCIS
Lung Cancer Incidence Higher for Young Women Than Young Men
Lynparza OK’d as First-Line Maintenance of BRCA-Mutated Advanced Ovarian CA
Male Thyroid Cancer Survivors Face Higher CVD Risk
Many Breast Cancer Survivors Do Not Undergo Annual Surveillance
Many Oncologists Discuss, Recommend Medical Marijuana
Many Women Have Not Heard of Ovarian Cancer Before Diagnosis
Melanoma Survival Varies Among US States
Metformin, statins not associated with ovarian cancer
Mirvetuximab Gets Fast Track Status for Platinum-Resistant Ovarian Cancer
Models Project 79% Drop in Lung CA Mortality by 2065
Multi-analyte blood test detects 8 common cancers
Mutations Identified Distinguishing Metastatic from Early-Stage HR+/HER2- Breast Cancer
NCCN’s anticancer drug recommendations beyond FDA approval based on weak evidence
New Method Estimates Risk for Recurrence in Breast Cancer
Newer Hormonal Contraception May Cut Ovarian Cancer Risk
No Difference in CEA vs CA125/CEA Ratio for Identifying Ovarian Masses
No Increased Risk for Cancer for ART-Conceived Children
Olaparib Treatment May Improve Health-Related Quality of Life in Germline BRCA1/2-Mutated Ovarian Cancer
Open Surgery for Early Lung Cancer Tied to Long-Term Opioid Use
Ovarian Cancer Patients May Benefit From Trabectedin With PLD
Ovarian Cancer Risk Linked to Ultrasonographic Characteristics of Ovarian Masses
Ovarian Cancer Risk Reduced With Regular, Low-Dose Aspirin
Ovarian Cancer Screening: Assessing the Risks and Benefits
Ovarian cancer may be paternally inherited
Ovarian cancer patients may benefit from added hyperthermic intraperitoneal chemotherapy
Ovarian cancer risk reduced with oral contraceptives
Ovarian cancer screening: updated recommendations from the USPSTF
PAs Have Lower Diagnostic Accuracy for Melanoma Compared With Dermatologists
PSA Level 3 Months After Radiation Treatment May Predict Outcome
PSA Testing Not Recommended for Prostate Cancer Screening
Patient Interest Fairly High for Melanoma Genetic Risk Testing
Personalized Cancer Vaccine Looks Promising in Early Study
Physical Activity Associated With Reduced Risk of Hepatocellular Carcinoma
Postmenopausal Women With Normal BMI May Still Be at Increased Risk for Breast Cancer
Primary Care May Aid Genetic Counseling Referral for Ovarian Cancer Survivors
Progress Report in Cancer Control: How Are We Doing?
Prophylactic, Extended Carboplatin Infusion Not Linked to Lower HSR in Ovarian Cancer Patients
Prostate-specific antigen screening helps prostate cancer detection
Psychoeducational Intervention of Little Benefit in Breast Cancer
Quality of Life Decreased in Women With Breast Cancer During or Shortly After Pregnancy
Quality of Life Maintained With Niraparib for Ovarian Cancer
Quantitative Image Marker Beneficial for Identifying Response to Postsurgical Chemotherapy in Ovarian Cancer
RSNA: Mammography Has Value in Women Age 75 or Older
RSNA: Mammography May Benefit 30-Year-Olds With Risk Factors
Real-World Experience Differs from Trial Results for Niraparib in Recurrent Ovarian Cancer
Ribociclib FDA-Approved For Additional Indications in HR+, HER2- Advanced Breast Cancer
Risk for Suicide Increased in Year After Cancer Diagnosis
Risk for Zoster Up Before Diagnosis, During Treament of Hematologic Cancer
Risk of Breast Cancer Higher for African American Female Veterans
Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day
Screening for Ovarian Cancer in Low-Risk Women Influenced by Clinician Personal Experience
Screening for Prostate Cancer: USPSTF Recommendation Statement
Second Opinion at NCI Center Valuable for Breast CA Patients
Severe Folate Deficiency Associated With Olaparib for Relapsed Ovarian Cancer
TAILORx Shows Black Women With Breast Cancer Have Worse Clinical Outcomes
TNFi Not Linked to Increased Cancer Recurrence in RA Patients
Talazoparib Shows Antitumor Activity in Advanced Breast Cancer, Germline BRCA Mutation
Talzenna Approved for Germline BRCA-Mutated, HER2-Negative Breast Cancer
Tobacco Use Remains Leading Modifiable Cause of Cancer
Tucatinib May Be A Safe, Novel Treatment for ERBB2/HER2-Positive Breast Cancer
USPSTF Recommends Risk-Reducing Meds for Breast Cancer
USPSTF Updates Guidance for Cervical Cancer Screening
USPSTF recommends skin cancer prevention care to begin at age 6 months
Ultra-processed foods may increase overall, breast cancer risks
Ultrasound Beneficial for Diagnosing Pure Clear Cell Carcinoma of the Ovary
Want to read more?
Next post in Oncology
